Ironwood Pharmaceuticals, Inc. - Class A (IRWD) Dividend History

Company News

• Ironwood Pharmaceuticals Stock Plunges, FDA Wants Another Trial For Gastrointestinal Drug

  Ironwood Pharmaceuticals' stock plunged after the FDA requested a confirmatory Phase 3 trial for its gastrointestinal drug apraglutide, despite strong data from the initial trial.

  Benzinga

  Featured Companies: GS
• Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer

  Beam Therapeutics, a biotechnology company developing precision genetic medicines, has appointed Sravan K. Emany as its new Chief Financial Officer. Emany brings extensive experience in the life sciences industry and will help guide Beam's growth and capital allocation strategy.

  GlobeNewswire Inc.

  Featured Companies: ASRT BEAM IART
• New Strong Sell Stocks for July 5th - Zacks Investment Research

  Three stocks were added to the Zacks Rank #5 (Strong Sell) list today: Arcos Dorados Holdings Inc., Ironwood Pharmaceuticals, Inc., and Avnet, Inc. The Zacks Consensus Estimate for their current year earnings has been revised downward over the last 60 days.

  Zacks Investment Research

  Featured Companies: ARCO AVT
• The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

  A more selective small-cap index has consistently outperformed the Russell 2000

  MarketWatch

  Featured Companies: ACRV ALLO ARLO ATNM CMPX CPRX CRBU DGII DVAX GPRE HLX IJR INZY IPSC IWM KPTI LCTX LGND MODV PAYO PCRX PRVA PTEN RCUS RLYB RNA SMTC SPY STOK TALO THRY TNYA TRVI VIGL VIR VOR XFOR XNCR XPER
• Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround

  Ironwood's plan to purchase a smaller biotech should address some issues that have shareholders concerned.

  The Motley Fool